Provided by Tiger Fintech (Singapore) Pte. Ltd.

iBio

1.00
-0.0500-4.76%
Volume:464.12K
Turnover:481.76K
Market Cap:9.87M
PE:-0.39
High:1.10
Open:1.03
Low:1.00
Close:1.05
Loading ...

BRIEF-Ibio Inc Enters Exclusive License Agreement With AstralBio

Reuters
·
23 Apr

iBio Enters Licensing Agreement for Obesity Treatment

TIPRANKS
·
23 Apr

Ibio - Licensing Agreement With Astralbio for Preclinical First-in-Class Antibody Targeting Activin E

THOMSON REUTERS
·
23 Apr

Ibio Inc - Enters Exclusive License Agreement With Astralbio

THOMSON REUTERS
·
23 Apr

iBio Expands Cardiometabolic and Obesity Pipeline through Licensing of First-in-Class Antibody Targeting Activin E from AstralBio

GlobeNewswire
·
22 Apr

Pharma Stocks Sink After Trump Says "Major" Tariffs Are Coming

Tiger Newspress
·
09 Apr

BRIEF-Ibio Inc - On Track For Regulatory Submission For Ibio-600 In Q1 2026

Reuters
·
07 Apr

iBio Reveals Promising Study Results for IBIO-600

TIPRANKS
·
07 Apr

Ibio Inc - on Track for Regulatory Submission for Ibio-600 in Q1 2026

THOMSON REUTERS
·
07 Apr

Ibio Announces Ibio-600 Non-Human Primate Data Showing Extended Half-Life and Muscle Growth, and Interim in Vivo Results for First-in-Class Activin E Antibody, Advancing Cardiometabolic and Obesity Pipeline

THOMSON REUTERS
·
07 Apr

iBio Announces IBIO-600 Non-Human Primate Data Showing Extended Half-Life and Muscle Growth, and Interim In Vivo Results for First-in-Class Activin E Antibody, Advancing Cardiometabolic and Obesity Pipeline

GlobeNewswire
·
07 Apr

Pharma Stocks Survive Market Rout on Tariff Exemption, but Uncertainty Continues

Reuters
·
03 Apr

iBio, Inc. Common Stock (IBIO): Among Stocks Insiders Were Buying In Q1 2025

Insider Monkey
·
01 Apr

Pharma Stocks Sink After Ouster of Top FDA Vaccine Regulator

Reuters
·
31 Mar

IBio Inc. Stock Rises Monday, Outperforms Market

Dow Jones
·
04 Mar

IBio Inc. Stock Rises Friday, Outperforms Market

Dow Jones
·
01 Mar

IBio Inc. Stock Falls Wednesday, Underperforms Market

Dow Jones
·
27 Feb

IBio Inc. Stock Falls Monday, Still Outperforms Market

Dow Jones
·
25 Feb

iBio, Inc. Advances in Therapeutics and Leadership

TIPRANKS
·
22 Feb

IBio Inc. Stock Falls Friday, Underperforms Market

Dow Jones
·
22 Feb